HS6ST1

HS6ST1 is a heparan sulfate 6-O-sulfotransferase that modulates extracellular morphogen gradients and downstream signaling to regulate developmental patterning and neuroendocrine function. By catalyzing 6-O-sulfation of heparan sulfate chains, HS6ST1 shapes FGF8 protein distribution and restrains FGF8/ERK signaling intensity in the developing telencephalic midline; loss of this activity causes corpus callosum agenesis through precocious glial accumulation and ERK hyperactivation, a phenotype rescued by genetic or pharmacological suppression of the FGF8/ERK axis (PMID:24501377, PMID:29158323). In Xenopus neuroectoderm, HS6ST1-mediated sulfation differentially retains Fgf8a on expressing cells while dispersing the BMP antagonist Noggin, thereby patterning the neural plate (PMID:36739958). A loss-of-function missense mutation in HS6ST1 causes familial delayed puberty in humans, and heterozygous loss in mice delays pubertal onset without reducing GnRH neuron number, establishing HS6ST1 as a regulator of puberty timing (PMID:29931354).

1. 2012 Medium

   HS6ST1 was shown to create spatially restricted zones of high 6-O-sulfation at prostatic epithelial bud tips that support FGF10/ERK signaling, establishing that its sulfotransferase activity has localized signaling consequences in developing tissues.

   Evidence In situ hybridization, immunohistochemistry for 6-O-sulfated HS, and BMP treatment of urogenital sinus explants in mouse

   PMID:23074159

   Open questions at the time

   • Functional consequence of Hs6st1 loss in prostate branching not tested by knockout
   • Relationship between 6-O-sulfation and FGF10 binding affinity not biochemically resolved
2. 2014 High

   Hs6st1 knockout in mice revealed that 6-O-sulfation acts upstream of FGF8/ERK signaling in corpus callosum formation, with loss causing glial fate precocity and axon guidance failure—both rescued by reducing FGF8 or ERK activity.

   Evidence Hs6st1−/− mouse analysis with immunohistochemistry, Western blotting, genetic crosses to Fgf8 hypomorphs, and pharmacological ERK inhibition

   PMID:24501377

   Open questions at the time

   • Whether HS6ST1 directly modifies HS chains that bind FGF8 or acts through intermediate proteoglycans is unresolved
   • Cell-type-specific contributions (glia vs. neurons) not dissected with conditional knockouts
3. 2017 High

   Ex vivo gradient assays demonstrated that Hs6st1 directly shapes extracellular FGF8 protein gradients and normally restrains ERK hyperactivation, resolving how loss of 6-O-sulfation leads to both elevated FGF8 levels and excessive signaling.

   Evidence Ex vivo neural tissue cultures from Hs6st1−/− embryos challenged with exogenous FGF8, with immunofluorescence for FGF8 gradient and pERK

   PMID:29158323

   Open questions at the time

   • Mechanism by which 6-O-sulfation accelerates FGF8 gradient formation (diffusion vs. degradation vs. receptor turnover) not distinguished
   • Whether this gradient-shaping function applies to other FGF family members is untested
4. 2018 High

   A human HS6ST1 missense mutation causing reduced enzymatic activity was linked to familial delayed puberty, extending the gene's role from brain morphogenesis to neuroendocrine control of puberty onset.

   Evidence In vitro sulfotransferase assay of mutant protein; Hs6st1+/− mouse phenotyping for vaginal opening timing and GnRH neuron counts

   PMID:29931354

   Open questions at the time

   • Downstream signaling pathway mediating puberty delay (FGF vs. other HS-dependent ligands) not identified
   • Whether haploinsufficiency affects GnRH neuron migration, axon targeting, or secretory function is unknown
5. 2023 Medium

   Gain- and loss-of-function experiments in Xenopus showed that HS6ST1 differentially sorts morphogens—retaining FGF8 locally while dispersing Noggin—demonstrating a conserved morphogen-selective gradient mechanism in neuroectodermal patterning.

   Evidence mRNA overexpression and CRISPR/Cas9 knockout in Xenopus with immunostaining for Fgf8a and Noggin distribution

   PMID:36739958

   Open questions at the time

   • Biochemical basis for differential retention of FGF8 vs. dispersal of Noggin by 6-O-sulfated HS not defined
   • Contribution of other sulfotransferases to this selectivity not assessed

• Key unresolved questions include the structural basis for HS6ST1 substrate selectivity, the identity of specific HS proteoglycan carriers mediating its developmental effects, and whether its roles in FGF gradient regulation and TGF-β1 signaling share a common sulfation-dependent mechanism.
• No crystal structure of HS6ST1 with bound substrate
• Specific HSPG carriers (e.g., syndecan, glypican) mediating HS6ST1's effects in vivo are unidentified
• Whether FGF8 gradient regulation and TGF-β1 pathway support involve the same sulfated HS epitopes is untested